Phio Pharmaceuticals Corp. Q3 EPS $(1.14)
Portfolio Pulse from Benzinga Newsdesk
Phio Pharmaceuticals Corp. has reported a Q3 earnings per share (EPS) of $(1.14).

November 09, 2023 | 10:37 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Phio Pharmaceuticals Corp. reported a Q3 EPS of $(1.14).
Earnings per share (EPS) is a key indicator of a company's profitability. A negative EPS, as reported by Phio Pharmaceuticals Corp., typically indicates a company is not profitable during the reported period. This could potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 80
RELEVANCE 100